Acute effects of delta-9-tetrahydrocannabinol on performance monitoring in healthy volunteers

被引:18
作者
Spronk, Desiree [1 ,2 ]
Dumont, Glenn J. H. [1 ,3 ]
Verkes, Robbert J. [1 ,2 ]
de Bruijn, Ellen R. A. [2 ]
机构
[1] Radboud Univ Nijmegen, Ctr Med, Dept Psychiat, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands
[3] Moleman Psychopharmacol, Amerongen, Netherlands
关键词
performance monitoring; error-related negativity; ERN; cannabinoids; THC; human; cannabis; ERROR-RELATED-NEGATIVITY; CANNABIS USE; PREFRONTAL CORTEX; DOPAMINE RELEASE; NEURAL BASIS; BRAIN; THC; ALCOHOL; ATTENTION; MARIJUANA;
D O I
10.3389/fnbeh.2011.00059
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The error-related negativity (ERN) is a negative event-related potential that occurs immediately after an erroneous response and is thought to reflect human performance monitoring. Delta-9-Tetrahydrocannabinol (THC) administration in healthy volunteers has been linked to impaired performance monitoring in behavioral studies, but to date no studies have examined the effects of cannabinoids on the ERN. Methods: EEG data from 10 healthy volunteers was recorded during execution of a speeded choice-reaction time task (Flankers task) after administration of THC or placebo vapor in a double-blind randomized crossover design. Results: The findings of this study show that the ERN was significantly reduced after administration of THC. The behavioral outcomes on the Flankers task showed no indications of drug induced impairments. Discussion: The diminished ERN reflects impairments in the process of performance monitoring. The task design was not optimized to find behavioral effects. The study shows that cannabinoids impair performance monitoring.
引用
收藏
页数:11
相关论文
共 81 条
[1]   Vaporization as a smokeless cannabis delivery system: A pilot study [J].
Abrams, D. I. ;
Vizoso, H. P. ;
Shade, S. B. ;
Jay, C. ;
Kelly, M. E. ;
Benowitz, N. L. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (05) :572-578
[2]  
[Anonymous], 1990, PSYCHOPHYSIOLOGICAL
[3]   Adverse effects of cannabis and cannabinoids [J].
Ashton, CH .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (04) :637-649
[4]   Alcohol Effects on Performance Monitoring and Adjustment: Affect Modulation and Impairment of Evaluative Cognitive Control [J].
Bartholow, Bruce D. ;
Henry, Erika A. ;
Lust, Sarah A. ;
Saults, J. Scott ;
Wood, Phillip K. .
JOURNAL OF ABNORMAL PSYCHOLOGY, 2012, 121 (01) :173-186
[5]   WHERE DID I GO WRONG - A PSYCHOPHYSIOLOGICAL ANALYSIS OF ERROR-DETECTION [J].
BERNSTEIN, PS ;
SCHEFFERS, MK ;
COLES, MGH .
JOURNAL OF EXPERIMENTAL PSYCHOLOGY-HUMAN PERCEPTION AND PERFORMANCE, 1995, 21 (06) :1312-1322
[6]   Cannabis with high Δ9-THC contents affects perception and visual selective attention acutely: An event-related potential study [J].
Bocker, K. B. E. ;
Gerritsen, J. ;
Hunault, C. C. ;
Kruidenier, M. ;
Mensinga, Tj. T. ;
Kenemans, J. L. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 96 (01) :67-74
[7]   Alcohol promotes dopamine release in the human nucleus accumbens [J].
Boileau, I ;
Assaad, JM ;
Pihl, RO ;
Benkelfat, C ;
Leyton, M ;
Diksic, M ;
Tremblay, RE ;
Dagher, A .
SYNAPSE, 2003, 49 (04) :226-231
[8]   Mental fatigue, motivation and action monitoring [J].
Boksem, MAS ;
Meijman, TF ;
Lorist, MM .
BIOLOGICAL PSYCHOLOGY, 2006, 72 (02) :123-132
[9]   Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition [J].
Borgwardt, Stefan J. ;
Allen, Paul ;
Bhattacharyya, Sagnik ;
Fusar-Poli, Paolo ;
Crippa, Jose A. ;
Seal, Marc L. ;
Fraccaro, Valter ;
Atakan, Zerrin ;
Martin-Santos, Rocio ;
O'Carroll, Colin ;
Rubia, Katya ;
McGuire, Philip K. .
BIOLOGICAL PSYCHIATRY, 2008, 64 (11) :966-973
[10]   Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum [J].
Bossong, Matthijs G. ;
van Berckel, Bart N. M. ;
Boellaard, Ronald ;
Zuurman, Lineke ;
Schuit, Robert C. ;
Windhorst, Albert D. ;
van Gerven, Joop M. A. ;
Ramsey, Nick F. ;
Lammertsma, Adriaan A. ;
Kahn, Rene S. .
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (03) :759-766